Monster (NASDAQ:MNST) Surprises With Q2 CY2026 Sales
Monster Beverage (NASDAQ: MNST) reported Q2 CY2026 sales of $2.54 billion, up 20.2% year on year, topping Wall Street revenue expectations by 4.1%. Non-GAAP profit was $0.60 per share, about 3% above consensus. The article notes trailing 12-month revenue of $9.22 billion and a free cash flow margin averaging 24.4% over two years.
How this was made
The 30-second read
Why it matters
For traders, the key actionable element is the reported beat versus Wall Street estimates (revenue topped estimates by 4.1%, EPS 3% above consensus). However, the article also states the stock remained flat at $94.70 immediately following results, implying limited immediate repricing.
Market read
Earnings beat with a flat immediate reaction suggests the print may confirm expectations rather than overturn them.
What to watch
The article does not provide margin drivers, guidance details beyond a revenue growth expectation, or channel/inventory commentary that could explain whether the beat is sustainable.
Background
Monster Beverage’s Q2 CY2026 results are framed as exceeding revenue expectations, with sales growth and non-GAAP EPS above consensus.
Ticker impact
Monster Beverage reported Q2 CY2026 sales up 20.2% to $2.54B and non-GAAP EPS of $0.60, beating revenue and consensus.
Near-term bias modestly positive, with limited follow-through implied by the flat immediate reaction.
The text provides concrete Q2 figures versus expectations, but offers no new guidance beyond a general next-12-month revenue growth expectation and no catalyst beyond the earnings print.
Market effects
Reinforces resilience in consumer staples and energy drink demand, potentially supporting sector sentiment.
No regional-specific demand or regulatory details provided.
No international expansion or FX sensitivity details provided.
Counterpoint
A flat immediate stock reaction suggests the market may have already priced in the beat, limiting incremental upside from this print alone.
Key entities
- companyMonster Beverage
Energy drink company reporting Q2 CY2026 sales and non-GAAP EPS versus consensus.
